|
Tomasson, M H; Williams, I R; Li, S et al. (2001) Induction of myeloproliferative disease in mice by tyrosine kinase fusion oncogenes does not require granulocyte-macrophage colony-stimulating factor or interleukin-3. Blood 97:1435-41
|
|
Van Etten, R A (2001) Retroviral transduction models of Ph+ leukemia: advantages and limitations for modeling human hematological malignancies in mice. Blood Cells Mol Dis 27:201-5
|
|
Roumiantsev, S; de Aos, I E; Varticovski, L et al. (2001) The src homology 2 domain of Bcr/Abl is required for efficient induction of chronic myeloid leukemia-like disease in mice but not for lymphoid leukemogenesis or activation of phosphatidylinositol 3-kinase. Blood 97:4-13
|
|
Li, S; Gillessen, S; Tomasson, M H et al. (2001) Interleukin 3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL. Blood 97:1442-50
|
|
Van Etten, R A (2001) Models of chronic myeloid leukemia. Curr Oncol Rep 3:228-37
|
|
Million, R P; Van Etten, R A (2000) The Grb2 binding site is required for the induction of chronic myeloid leukemia-like disease in mice by the Bcr/Abl tyrosine kinase. Blood 96:664-70
|
|
Li, S; Ilaria Jr, R L; Million, R P et al. (1999) The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. J Exp Med 189:1399-412
|
|
Ilaria Jr, R L; Hawley, R G; Van Etten, R A (1999) Dominant negative mutants implicate STAT5 in myeloid cell proliferation and neutrophil differentiation. Blood 93:4154-66
|
